oseltamivir has been researched along with Benign Neoplasms in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 14 (82.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A; Pooniya, V; Verma, N | 1 |
| Doganis, D; Giannouli, G; Goussetis, E; Kattamis, A; Kosmidis, H; Kottaridi, C; Kourlamba, G; Paisiou, A; Papadakis, V; Papaevangelou, V; Polychronopoulou, S; Priftis, K; Syridou, G; Tourkantoni, N; Vliora, C; Zaoutis, T | 1 |
| Haxho, F; Neufeld, RJ; Szewczuk, MR | 1 |
| Berger, A; Christopeit, M; Hauf, E; Hentrich, M; Heussel, CP; Kalkreuth, J; Klein, M; Kochanek, M; Lehners, N; Mayer, K; Penack, O; Rieger, C; Schalk, E; Silling, G; Vehreschild, M; von Lilienfeld-Toal, M; Weber, T; Wolf, HH | 1 |
| Boden, K; Brodhun, M; Hermann, B; Hochhaus, A; Kochanek, M; Lehners, N; Mayer, K; Meckel, K; Rachow, T; Rieger, C; Schalk, E; Schlattmann, P; Schmeier-Jürchott, A; Teschner, D; von Lilienfeld-Toal, M; Weber, T | 1 |
| Crawford, SM | 1 |
| Barrière, J; Coindard, G; Cua, E; Otto, J; Peyrade, F | 1 |
| Adams-Huet, B; Ardura, MI; Brock, E; Cost, C; Siegel, JD | 1 |
| Chen, L; Greenwald, I; Wolfe, C | 1 |
| Adderson, EE; Caniza, M; Carr, S; Franks, J; Govorkova, EA; Ilyushina, NA; Webster, RG | 1 |
| Amayiri, N; Madanat, F | 1 |
| Bozza, FA; de Lourdes Oliveira, M; Gonçalves, VM; Gubareva, LV; Marques, VP; Mesquita, M; Mishin, VP; Motta, FC; Pitrowsky, MT; Rocco, SA; Salluh, JI; Siqueira, MM; Soares, M; Souza, TM; Velasco, E; Whitney, A | 1 |
| Abid, S; Cuffari, C; Liu, D; Montecalvo, M; Nadelman, RB; Sandoval, C; Seiter, K; Shah, D; Shi, Q; Sinaki, B | 1 |
| Angeles-Garay, U; Arias-Flores, R; Gayosso Rivera, JA; Rechy-Luna, M; Terrazas Estrada, JJ; Zacate-Palacios, Y | 1 |
| Dix, D; Ethier, MC; Gassas, A; Johnston, DL; Portwine, C; Science, M; Sung, L; Tran, D; Yanofsky, R; Zelcer, S | 1 |
| Adams, O; Babor, F; Bienemann, K; Borkhardt, A; Grund, S; Janßen, G; Kuhlen, M; Laws, HJ; Meisel, R; Oommen, PT; Schuster, FR; Siepermann, M; Wessalowski, R | 1 |
| Chan, PK; Chik, KW; Lee, V; Li, CK; Shing, MM; Tam, JS; Yuen, PM | 1 |
2 review(s) available for oseltamivir and Benign Neoplasms
| Article | Year |
|---|---|
Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis.
Topics: Animals; Breast Neoplasms; Carcinogenesis; Cell Survival; Disease Progression; Drug Resistance, Neoplasm; Enzyme Activation; ErbB Receptors; Female; Humans; Macrophages; Matrix Metalloproteinase 9; Mice; Mutation; Neoplasm Metastasis; Neoplasms; Neuraminidase; Oseltamivir; Ovarian Neoplasms; Receptor Protein-Tyrosine Kinases; Signal Transduction | 2016 |
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.
Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Community-Acquired Infections; Cytosine; Germany; Hand Hygiene; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Influenza, Human; Lung; Masks; Medical Oncology; Metapneumovirus; Neoplasms; Neuraminidase; Nucleic Acid Amplification Techniques; Organophosphonates; Oseltamivir; Paramyxoviridae Infections; Patient Isolation; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Tomography, X-Ray Computed; Virus Diseases | 2016 |
1 trial(s) available for oseltamivir and Benign Neoplasms
| Article | Year |
|---|---|
Oseltamivir prophylaxis during the influenza season in a paediatric cancer centre: prospective observational study.
Topics: Acetamides; Administration, Oral; Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hong Kong; Hospitals, Pediatric; Humans; Immunocompromised Host; Incidence; Influenza, Human; Male; Neoplasms; Oncology Service, Hospital; Oseltamivir; Prospective Studies; Risk Assessment; Treatment Outcome | 2004 |
14 other study(ies) available for oseltamivir and Benign Neoplasms
| Article | Year |
|---|---|
Clinical Profile and Outcome of Influenza A/H1N1 in Pediatric Oncology Patients During the 2015 Outbreak: A Single Center Experience from Northern India.
Topics: Antineoplastic Agents; Antiviral Agents; Child; Disease Outbreaks; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neoplasms; Oseltamivir; Retrospective Studies; Treatment Outcome | 2017 |
A prospective study on the epidemiology and clinical significance of viral respiratory infections among pediatric oncology patients.
Topics: Child; Child, Preschool; Female; Follow-Up Studies; Hospitalization; Humans; Influenza, Human; Male; Neoplasms; Oseltamivir; Prevalence; Prospective Studies | 2019 |
Influenza virus infections in patients with malignancies -- characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO).
Topics: Aged; Antiviral Agents; Critical Care; Female; Germany; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Male; Middle Aged; Neoplasms; Oseltamivir; Risk Factors; Societies; Superinfection; Survival Analysis; Treatment Outcome | 2017 |
A/H1N1 flu pandemic. Managing neutropenic sepsis.
Topics: Antineoplastic Agents; Antiviral Agents; Diagnosis, Differential; Fever; Humans; Infection Control; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neoplasms; Neutropenia; Oseltamivir | 2009 |
[New influenza A (H1N1) pandemia and cancer patients: what do we do?].
Topics: Antiviral Agents; Disease Outbreaks; Hospitalization; Humans; Immunization Schedule; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Neoplasms; Neutropenia; Oseltamivir; Streptococcal Vaccines | 2009 |
2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients.
Topics: Adolescent; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Neoplasms; Oseltamivir; Pandemics; Retrospective Studies; Treatment Outcome | 2011 |
Pandemic (H1N1) 2009 and oseltamivir resistance in hematology/oncology patients.
Topics: Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Neoplasms; Oseltamivir; Pandemics | 2010 |
Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Drug Resistance, Viral; Humans; Immunocompromised Host; Infant; Influenza A virus; Influenza B virus; Influenza, Human; Microbial Sensitivity Tests; Neoplasms; Neuraminidase; Oseltamivir; Sequence Analysis, DNA; Viral Matrix Proteins; Viral Proteins; Young Adult | 2011 |
Retrospective analysis of pediatric cancer patients diagnosed with the pandemic H1N1 influenza infection.
Topics: Adolescent; Child; Child, Preschool; Fever; Hematologic Neoplasms; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neoplasms; Oseltamivir; Pandemics; Retrospective Studies; Time Factors; Young Adult | 2011 |
H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Biological Evolution; Brazil; Child; Child, Preschool; Comorbidity; Female; Hospital Mortality; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Neoplasms; Oseltamivir; Pandemics; Prospective Studies; Virus Shedding; Young Adult | 2010 |
Prospective evaluation of 2009 H1N1 influenza A in patients admitted with fever to an oncology unit.
Topics: Adult; Antiviral Agents; Child; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Middle Aged; Neoplasms; Oncology Service, Hospital; Oseltamivir; Prospective Studies; Treatment Outcome | 2011 |
[Clinical features and contagiousness of influenza A(H1N1) in health care workers and hospitalized patients in a Mexico City hospital].
Topics: Adult; Aged; Antiviral Agents; Comorbidity; Contact Tracing; Cross Infection; Disease Outbreaks; Female; Hospital Mortality; Hospitals, Urban; Humans; Immunocompromised Host; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Professional-to-Patient; Influenza A Virus, H1N1 Subtype; Influenza, Human; Inpatients; Male; Mexico; Middle Aged; Neoplasms; Occupational Diseases; Oseltamivir; Personnel, Hospital; Virulence; Zanamivir | 2011 |
Pandemic (H1N1) 2009 influenza in Canadian pediatric cancer and hematopoietic stem cell transplant patients.
Topics: Adolescent; Antiviral Agents; Canada; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Hospitals, Pediatric; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Neoplasms; Oseltamivir; Retrospective Studies; Time Factors; Treatment Outcome; Virus Shedding | 2012 |
Epidemiology and clinical characteristics of pandemic (H1N1) 2009 influenza infection in pediatric hemato-oncology and hematopoietic stem cell transplantation patients.
Topics: Adolescent; Antineoplastic Agents; Antiviral Agents; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Neoplasms; Oseltamivir; Pandemics; Young Adult | 2012 |